Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Inflammation Research
Published in: Inflammation Research 6/2010

01-06-2010 | Book Review

Steven G. Elliott, MaryAnn Foote, Graham Molineux (eds): Erythropoietins, erythropoietic factors, and erythropoiesis. Molecular, cellular, preclinical, and clinical biology

2nd revised and extended edition, 2009, 348 p., Hardcover, Birkhäuser Verlag AG, Basel, Switzerland, ISBN 978-3-7643-8694-8

Author: Nagamani Bora

Published in: Inflammation Research | Issue 6/2010

Login to get access

Excerpt

This volume in the Milestones in Drug Therapy series lives up to its title and represents a wide ranging and up to date review of many aspects of erythropoiesis. It is divided into four sections: Background, Erythropoiesis-stimulating agents (ESA), Erythropoietin receptor (EPOR) and Clinical utility, with 16 chapters covering topics from morphological development of hematopoiesis to drug abuse by athletes. The range is even wider than the section headings suggest, covering the biology, the molecular regulation, the history of recombinant human erythropoietin, commercial production, development of biosimilar biotherapeutics, the pharmacokinetics, clinical utility, interaction with iron availability, abuse and the potential role of ESA in neuroprotection, on the cardiovascular system and their direct effects upon tumor cells. …
Metadata
Title
Steven G. Elliott, MaryAnn Foote, Graham Molineux (eds): Erythropoietins, erythropoietic factors, and erythropoiesis. Molecular, cellular, preclinical, and clinical biology
2nd revised and extended edition, 2009, 348 p., Hardcover, Birkhäuser Verlag AG, Basel, Switzerland, ISBN 978-3-7643-8694-8
Author
Nagamani Bora
Publication date
01-06-2010
Publisher
SP Birkhäuser Verlag Basel
Published in
Inflammation Research / Issue 6/2010
Print ISSN: 1023-3830
Electronic ISSN: 1420-908X
DOI
https://doi.org/10.1007/s00011-010-0186-4

Other articles of this Issue 6/2010

Inflammation Research 6/2010 Go to the issue

Original Research Paper

Hyaluronan reversed proteoglycan synthesis inhibited by mechanical stress: possible involvement of antioxidant effect

Original Research Paper

Plasma YKL-40 is elevated in patients with recurrent atrial fibrillation after catheter ablation

Original Research Paper

Sulforaphane suppresses LPS-induced inflammation in primary rat microglia

Original Research Paper

Protective effects of emodin combined with danshensu on experimental severe acute pancreatitis

Original Research Paper

Geniposide inhibits interleukin-6 and interleukin-8 production in lipopolysaccharide-induced human umbilical vein endothelial cells by blocking p38 and ERK1/2 signaling pathways

Original Research Paper

Impact of chlorhexidine mouth rinse use on postextraction infection via nitric oxide pathway
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits